Clinical Trials Directory

Trials / Completed

CompletedNCT01013350

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Studies (PREMIERE)

Status
Completed
Phase
Study type
Observational
Enrollment
1,161 (actual)
Sponsor
EMD Serono · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants who Have Participated in Cladribine Clinical Trials

Conditions

Timeline

Start date
2009-11-30
Primary completion
2018-10-25
Completion
2018-10-25
First posted
2009-11-13
Last updated
2019-11-15
Results posted
2019-11-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01013350. Inclusion in this directory is not an endorsement.